Johanna Friedl-Naderer - 03 Mar 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP & Chief Operating Officer
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
03 Mar 2023
Net transactions value
-$33,819
Form type
4
Filing time
07 Mar 2023, 13:04:22 UTC
Previous filing
24 Feb 2023
Next filing
03 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale $33,819 -1,482 -0.99% $22.82 148,518 03 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.